Response to: MR-proADM has a good ability to predict mortality in critically ill patients with SARS-CoV-2 pneumonia: Beware of some potential confounders!

van Oers, Jos A H; de Grooth, Harm-Jan; de Lange, Dylan W; Girbes, Armand R J

van Oers, Jos A H; de Grooth, Harm-Jan; de Lange, Dylan W; Girbes, Armand R J.

Afiliação

van Oers JAH; Department of Intensive Care Medicine, Elisabeth Tweesteden Ziekenhuis, Tilburg, the Netherlands. Electronic address: jah.vanoers@etz.nl.
de Grooth HJ; Department of Intensive Care Medicine, Amsterdam UMC, Medical Centres, VU University Medical Centre, Amsterdam, the Netherlands.
de Lange DW; Department of Intensive Care Medicine, University Medical Centre Utrecht, University Utrecht, Utrecht, the Netherlands.
Girbes ARJ; Department of Intensive Care Medicine, Amsterdam UMC, Medical Centres, VU University Medical Centre, Amsterdam, the Netherlands.

J Crit Care ; 67: 214-215, 2022 02.

Article em En | MEDLINE | ID: mdl-34688526

Assuntos

COVID-19; Pneumonia; Adrenomedulina; Estado Terminal; Humanos; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia / COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Crit Care Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google